Correspondence 0001104659-25-009108 from Cellectar Biosciences, Inc. (CLRB)
Cellectar Biosciences, Inc.
Date: Feb. 4, 2025 · CIK: 0001279704 · Accession: 0001104659-25-009108
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-284580
Letter
CELLECTAR BIOSCIENCES, INC.
100 Campus Drive
Florham Park, New Jersey 07932
February 4, 2025
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Joshua Gorsky
Re: Cellectar Biosciences, Inc.
Registration Statement on Form S-1
Filed January 29, 2025
File No. 333-284580
Ladies and Gentlemen:
Pursuant to Rule 461(a) under the Securities Act of 1933, as amended, Cellectar Biosciences, Inc., a Delaware corporation (the “Company”), hereby requests that the effective date of the Company’s Registration Statement on Form S-1 (Registration No. 333-284580), be accelerated so that the Registration Statement will become effective at 5:00 p.m. on February 6, 2025, or as soon as practicable thereafter.
The cooperation of the staff in meeting our request is very much appreciated. If you have any questions or comments, please contact Kostian Ciko (212-839-5450 or kciko@sidley.com). Thank you for your assistance with these matters.
Very truly yours,
CELLECTAR BIOSCIENCES, INC.
Show Raw Text
CORRESP
1
filename1.htm
CELLECTAR BIOSCIENCES, INC.
100 Campus Drive
Florham Park, New Jersey 07932
February 4, 2025
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Joshua Gorsky
Re:
Cellectar Biosciences, Inc.
Registration Statement on Form S-1
Filed January 29, 2025
File No. 333-284580
Ladies and Gentlemen:
Pursuant to Rule 461(a) under the Securities Act
of 1933, as amended, Cellectar Biosciences, Inc., a Delaware corporation (the “Company”), hereby requests that the effective
date of the Company’s Registration Statement on Form S-1 (Registration No. 333-284580), be accelerated so that the Registration
Statement will become effective at 5:00 p.m. on February 6, 2025, or as soon as practicable thereafter.
The cooperation
of the staff in meeting our request is very much appreciated. If you have any questions or comments, please contact Kostian Ciko (212-839-5450
or kciko@sidley.com). Thank you for your assistance with these matters.
Very truly yours,
CELLECTAR BIOSCIENCES, INC.
By:
/s/ Chad J. Kolean
Chad J. Kolean, Chief Financial Officer
cc:
James V. Caruso
Asher M. Rubin
Istvan A. Hajdu
Kostian Ciko